Why Is Pear Therapeutics (PEAR) Stock Down 26% Today?

Advertisement

  • Pear Therapeutics (PEAR) stock is sliding following its bankruptcy filing.
  • The stock has been volatile since the filing earlier this week.
  • This has shares seeing heavy trading volume today.
PEAR Stock - Why Is Pear Therapeutics (PEAR) Stock Down 26% Today?

Source: Room's Studio / Shutterstock

Pear Therapeutics (NASDAQ:PEAR) stock is falling on Friday after the company’s recent bankruptcy filing continues to weigh on its shares.

Pear Therapeutics announced its bankruptcy filing while markets were closed for Good Friday. As a result, the company’s stock underwent a major fall on Monday. Since then, its shares have been somewhat volatile with rises and falls throughout the week.

That continues on Friday with heavy trading sending shares of PEAR stock lower as investors sell their stakes. As of this writing, more than 14 million shares of the company’s stock have changed hands. That’s already well above the company’s daily average trading volume of 6.1 million shares.

What to Know About the Bankruptcy

Pear Therapeutics notes that its debtors are currently considering a sale of the business. That includes the possibility of selling the entire business to a buyer. If not, then the debtors will seek to sell assets from the business instead. That could result in multiple buyers acquiring parts of Pear Therapeutics.

Considering debtors’ plans for Pear Therapeutics, it makes sense that PEAR stock would be down. There doesn’t seem to be a future for shares of the company’s stock. At this rate, it’s likely PEAR will end up delisted.

PEAR stock is down 26.2% during pre-market trading on Friday!

Investors searching for more of the latest stock market news are in luck!

We’ve got all of the biggest stock stories worth reading about on Friday! A few examples include why shares of Petros Pharma (NASDAQ:PTPI) and CXApp (NASDAQ:CXAI) stock are up and more. You can find all of that news at the links below!

More Friday Stock Market News

On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com’s writers disclose this fact and warn readers of the risk.

Read More:Penny Stocks — How to Profit Without Getting Scammed

On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.


Article printed from InvestorPlace Media, https://investorplace.com/2023/04/why-is-pear-therapeutics-pear-stock-down-26-today/.

©2024 InvestorPlace Media, LLC